Contributors | |
Preface | |
Syncope and TLOC overview | |
Definition and classification of syncope and transient loss of consciousness | |
Epidemiologic aspects of transient loss of consciousness/syncope | |
Pathophysiology of syncope: postural, neurally-mediated, and arrhythmic | |
Cerebral perfusion in syncope | |
Risk stratification-impact on diagnostic strategy | |
Clinical evaluation strategies | |
Value and limitations of clinical history in assessing cause of syncope | |
Emergency department evaluation of transient loss of consciousness/syncope | |
The essential autonomic assessment for evaluating the cause of syncope | |
Neurally-mediated reflex syncope: recognition by history and clinical testing | |
Value and limitations of ambulatory electrocardiographic monitoring | |
Recording ambulatory blood pressure in the syncope and TLOC evaluation | |
Electrophysiologic testing: value and limitations in the transient loss of consciousness/syncope evaluation | |
Intolerance to upright posture in autonomic failure and the postural tachycardia syndrome: assessment and treatment strategies | |
Improving tolerance to upright posture: current status of tilt-training and other physical maneuvers | |
Syncope in patients with bundle-branch block and other conduction system abnormalities | |
Specific conditions | |
Treatment strategies in neurally-mediated reflex syncope: effectiveness of drugs, pacing, and physical maneuvers | |
Structural heart disease, syncope, and risk of sudden death: selection of patients for implantable cardioverter-defibrillator therapy | |
Channelopathies as a cause of syncope | |
Distinguishing seizures and pseudosyncope from syncope | |
Syncope and transient loss of consciousness in children and adolescents: congenital and acquired conditions | |
Transient loss of consciousness, syncope, and falls in the elderly | |
Drug-induced (iatrogenic) syncope | |
Economic and research aspects | |
Syncope and the competitive athlete: recommendations for evaluation and permission to compete | |
Role of syncope management units | |
The impact of syncope and transient loss of consciousness on quality of life | |
Current controversies and future directions | |
Driving and flying restrictions for the syncope and/or implanted cardiac device patient | |
Clinical trials landscape: what's new, what's ongoing, what do we need | |
Syncope and transient loss of consciousness: multidisciplinary management | |
Syncope practice guidelines initiative | |
Appendix: syncope consortium members | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.